US 10548953
Factor VIII-XTEN fusions and uses thereof
granted A61KA61K38/00A61K38/37
Quick answer
US patent 10548953 (Factor VIII-XTEN fusions and uses thereof) held by BIOVERATIV THERAPEUTICS INC. expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61K38/37, A61K48/00, A61K9/0019